Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1991-12-03
1993-03-30
Waddell, Frederick E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514912, 424427, A61K 31425
Patent
active
051984547
ABSTRACT:
A novel compound for the treatment and prevention of ocular inflammation is disclosed. The compound, OB-104, is effective at both the early and late phases of inflammation.
REFERENCES:
patent: 3896223 (1975-07-01), Ariyan et al.
Remington Pharmaceutical Sciences, fifteenth edition (1975), pp. 1491-1492.
Polansky et al., "Anti-Inflammatory Agents: Steriods as Anti-Inflammatory Agents", Sears, Ed., Handbook of Experimental Pharmacology Springer-Verlag, (1985) 69:459-538.
Miyano et al., Opthalmic Res. (1984) 16:256-263.
Chiou et al., J. Ocular Pharmacol. (1985)1(4):383-389.
Bhattercherjee et al., "Effects of Lipooxygenase Products on Leukocyte Accumulation in the Rabbit Eye" Samuelsson et al., Eds., Leukorienes and Other Lipooxygenase Products Raven Press (1982) pp. 325-330.
Chang et al., J. Ocular Pharmacol. (1989) 5(4):353-360.
Fay Zohreh A.
Texas A&M University System
Waddell Frederick E.
LandOfFree
Use of OB-104 to treat ocular inflammation does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of OB-104 to treat ocular inflammation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of OB-104 to treat ocular inflammation will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1281257